<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="07/07/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8613707" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8613707</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Transcriptional basis for hyporesponsiveness of the <term sem="DNA_domain_or_region" id="T1" lex="human_inducible_nitric_oxide_synthase_gene">human inducible <term sem="DNA_domain_or_region" id="T2" lex="nitric_oxide_synthase_gene">nitric oxide synthase gene</term></term> to <term sem="Lipid" id="A1">lipopolysaccharide</term>/<term sem="Protein_molecule" id="A2">interferon-gamma</term>.</sentence>
<event id="E1">
<type class="Regulation" />
<theme idref="T2" />
<cause idref="A1" />
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human inducible nitric oxide synthase gene <linkCause>to</linkCause> lipopolysaccharide/interferon-gamma.</clue>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref="T2" />
<cause idref="A2" />
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human inducible nitric oxide synthase gene <linkCause>to</linkCause> lipopolysaccharide/interferon-gamma.</clue>
</event>
<event id="E30">
<type class="Negative_regulation" />
<theme idref="E1" />
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma.</clue>
<comment>CAUTION: hypo</comment>
</event>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E2" />
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma.</clue>
<comment>CAUTION: hypo</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The work reported here resolves, at the level of gene regulation, the controversy as to whether or not <term sem="Cell_natural" id="T3" lex="human_monocytes/macrophage">human <term sem="Cell_natural" id="T4" lex="monocyte">monocytes</term>/<term sem="Cell_natural" id="A20">macrophages</term></term> can produce <term sem="Inorganic_compound" id="T5" lex="nitric_oxide">nitric oxide</term> (<term sem="Inorganic_compound" id="T6" lex="NO">NO</term>) when stimulated with <term sem="Lipid" id="T7" lex="lipopolysaccharide">lipopolysaccharide</term> (<term sem="Lipid" id="T8" lex="LPS">LPS</term>), with or without co-stimulation by interferon-gamma (<term sem="Protein_molecule" id="T9" lex="IFN-gamma">IFN-gamma</term>).</sentence>
<event id="E171">
<type class="Physiological_process" />
<theme idref="T3" />
<cause idref="T8" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when <clueType>stimulated</clueType> <linkTheme>with</linkTheme> lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event id="E172">
<type class="Physiological_process" />
<theme idref="A20" />
<cause idref="T8" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when <clueType>stimulated</clueType> <linkTheme>with</linkTheme> lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event id="E173">
<type class="Physiological_process" />
<theme idref="T3" />
<cause idref="T9" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), with or without <clueType>co-stimulation</clueType> <linkTheme>by</linkTheme> interferon-gamma (IFN-gamma).</clue>
</event>
<event id="E174">
<type class="Physiological_process" />
<theme idref="A20" />
<cause idref="T9" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), with or without <clueType>co-stimulation</clueType> <linkTheme>by</linkTheme> interferon-gamma (IFN-gamma).</clue>
</event>
<event uncertainty="doubtful" id="E175">
<type class="Positive_regulation" />
<theme idref="T6" />
<cause idref="E171" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) <linkCause>when</linkCause> stimulated with lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event uncertainty="doubtful" id="E176">
<type class="Positive_regulation" />
<theme idref="T6" />
<cause idref="E172" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) <linkCause>when</linkCause> stimulated with lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event uncertainty="doubtful" id="E177">
<type class="Positive_regulation" />
<theme idref="T6" />
<cause idref="E171" />
<cause idref="E173" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), <linkCause>with</linkCause> or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event uncertainty="doubtful" id="E178">
<type class="Positive_regulation" />
<theme idref="T6" />
<cause idref="E172" />
<cause idref="E174" />
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), <linkCause>with</linkCause> or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<sentence id="S3">Studies included structural comparison of the promoters for <term sem="Multicellular_organism_natural" id="T10" lex="human">human</term> and <term sem="Multicellular_organism_natural" id="T11" lex="mouse">mouse</term> <term sem="DNA_family_or_group" id="T12" lex="inducible_NO_synthase_(iNOS)_gene"><term sem="Protein_molecule" id="T13" lex="inducible_NO_synthase">inducible <term sem="Inorganic_compound" id="T14" lex="NO">NO</term> synthase</term> (<term sem="Protein_molecule" id="T15" lex="iNOS">iNOS</term>) genes</term>, <term sem="Other" id="T16" lex="transfection_and_assay">transfection and assay</term> of human and mouse <term sem="DNA_domain_or_region" id="T17" lex="iNOS_promoter_region"><term sem="Protein_molecule" id="T18" lex="iNOS">iNOS</term> promoter regions</term> in response to <term sem="Lipid" id="T19" lex="LPS">LPS</term> +/- <term sem="Protein_molecule" id="T20" lex="IFN-gamma">IFN-gamma</term>, and <term sem="Other" id="T21" lex="electrophoretic_mobility_shift_assay">electrophoretic mobility shift assays</term> of <term sem="DNA_domain_or_region" id="T22" lex="kappa_B_response_element">kappa B response elements</term>.</sentence>
<event uncertainty="doubtful" id="E5">
<type class="Regulation" />
<theme idref="T17" />
<cause idref="T19" />
<clue>Studies included structural comparison of the promoters for human and mouse inducible NO synthase (iNOS) genes, transfection and assay of human and mouse iNOS promoter regions in <clueType>response</clueType> <linkCause>to</linkCause> LPS +/- IFN-gamma, and electrophoretic mobility shift assays of kappa B response elements.</clue>
</event>
<event uncertainty="doubtful" id="E6">
<type class="Regulation" />
<theme idref="T17" />
<cause idref="T19" />
<cause idref="T20" />
<clue>Studies included structural comparison of the promoters for human and mouse inducible NO synthase (iNOS) genes, transfection and assay of human and mouse iNOS promoter regions in <clueType>response</clueType> <linkCause>to</linkCause> LPS +/- IFN-gamma, and electrophoretic mobility shift assays of kappa B response elements.</clue>
</event>
<sentence id="S4">Two explanations for hyporesponsiveness of the <term sem="DNA_domain_or_region" id="T23" lex="human_iNOS_promoter">human <term sem="Protein_molecule" id="T24" lex="iNOS">iNOS</term> promoter</term> to <term sem="Lipid" id="T25" lex="LPS">LPS</term> +/- <term sem="Protein_molecule" id="T26" lex="IFN-gamma">IFN-gamma</term> were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the <term sem="DNA_domain_or_region" id="T27" lex="enhancer_element">enhancer element</term> that has been shown to regulate <term sem="Lipid" id="T28" lex="LPS">LPS</term>/<term sem="Other" id="T29" lex="IFN-gamma_induced_expression"><term sem="Protein_molecule" id="T30" lex="IFN-gamma">IFN-gamma</term> induced expression</term> of the <term sem="DNA_domain_or_region" id="T31" lex="mouse_iNOS_gene">mouse <term sem="Protein_molecule" id="T32" lex="iNOS">iNOS</term> gene</term>; and (2) and absence of one or more <term sem="Protein_family_or_group" id="T33" lex="nuclear_factor">nuclear factors</term> in <term sem="Cell_natural" id="T34" lex="human_macrophage">human macrophages</term> (e.g., an <term sem="Protein_complex" id="T35" lex="LPS-inducible_nuclear_factor-kappa_B/Rel_complex"><term sem="Lipid" id="T36" lex="LPS">LPS</term>-inducible nuclear factor-kappa B/<term sem="Protein_family_or_group" id="T37" lex="Rel">Rel</term> complex</term>), that is (are) required for maximal expression of the gene.</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="T23" />
<cause idref="T25" />
<clue>Two explanations for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human iNOS promoter <linkCause>to</linkCause> LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E8">
<type class="Regulation" />
<theme idref="T23" />
<cause idref="T25" />
<cause idref="T26" />
<clue>Two explanations for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human iNOS promoter <linkCause>to</linkCause> LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="E7" />
<clue>Two explanations for <clueType>hyporesponsiveness</clueType> of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
<comment>CAUTION: hypo</comment>
</event>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="E8" />
<clue>Two explanations for <clueType>hyporesponsiveness</clueType> of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
<comment>CAUTION: hypo</comment>
</event>
<event id="E11">
<type class="Mutagenesis" />
<theme idref="T27" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating <clueType>nucleotide substitutions</clueType> <linkTheme>in</linkTheme> the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E12">
<type class="Gene_expression" />
<theme idref="T31" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced <clueType>expression</clueType> <linkTheme>of</linkTheme> the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E61">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="T28" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma <clueType>induced</clueType> expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E62">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="T30" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma <clueType>induced</clueType> expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="E61" />
<cause idref="E11" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple <clueType>inactivating</clueType> nucleotide substitutions in the human counterpart of the enhancer element that has been shown to <clueType>regulate</clueType> LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E81">
<type class="Negative_regulation" />
<theme idref="E62" />
<cause idref="E11" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple <clueType>inactivating</clueType> nucleotide substitutions in the human counterpart of the enhancer element that has been shown to <clueType>regulate</clueType> LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="T33" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and <clueType>absence</clueType> <linkTheme>of</linkTheme> one or more nuclear factors <clueLoc>in human macrophages</clueLoc> (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E82">
<type class="Negative_regulation" />
<theme idref="T35" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and <clueType>absence</clueType> <linkTheme>of</linkTheme> one or more <corefTheme>nuclear factors</corefTheme> <clueLoc>in human macrophages</clueLoc> (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E15">
<type class="Gene_expression" />
<theme idref="T31" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>the gene</corefTheme>.</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T33" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) <clueType>required</clueType> <linkTheme>for</linkTheme> maximal expression of the gene.</clue>
</event>
<event id="E83">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T35" />
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) <clueType>required</clueType> <linkTheme>for</linkTheme> maximal expression of the gene.</clue>
</event>
<event id="E84">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="E13" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E85">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="E81" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E86">
<type class="Positive_regulation" />
<theme idref="E10" />
<cause idref="E13" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E87">
<type class="Positive_regulation" />
<theme idref="E10" />
<cause idref="E81" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E88">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="E14" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E89">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="E82" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E90">
<type class="Positive_regulation" />
<theme idref="E10" />
<cause idref="E14" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event id="E91">
<type class="Positive_regulation" />
<theme idref="E10" />
<cause idref="E82" />
<clue>Two <clueType>explanations</clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<sentence id="S5">The importance of resolution of this controversy is that future research in this area should be directed toward the understanding of alternative mechanisms that can result in the successful production of <term sem="Inorganic_compound" id="T38" lex="NO">NO</term>.</sentence>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="T38" />
<clue>The importance of resolution of this controversy is that future research in this area should be directed toward the understanding of alternative mechanisms that can result in the successful <clueType>production</clueType> <linkTheme>of</linkTheme> NO.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
